Bristol-Myers Squibb Co (NYSE:BMY)

58.28
Real-Time Quote
 +4.12 / +7.61%
Today’s Change
46.30
Today|||52-Week Range
59.03
+9.65%
Year-to-Date
5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know
11:19am / MotleyFool.com
Bristol-Myers Squibb (BMY) Stock Higher After Announcing Third Quarter Earnings Resul...
Oct 24 / TheStreet.com
QLT (QLTI) Reports Narrower-than-Expected Q3 Loss - Analyst Blog
9:45am / Zacks.com
UPDATE: Bristol-Myers Squibb Q3 Earnings Top Estimates
Oct 24 / Benzinga
Bristol-Myers Squibb Company (BMY) Leading In Pre-Market Activity
9:42am / TheStreet.com
#PreMarket Primer: Friday, October 24: Ebola Fears Weigh On Markets
Oct 24 / Benzinga
Will Teva (TEVA) Beat Q3 Earnings on Strong Generic Sales? - Analyst Blog
Oct 29 / Zacks.com
Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street
Oct 24 / MotleyFool.com
Insider Trading Alert - BLUE, CHRW And BMY Traded By Insiders
Oct 29 / TheStreet.com
Earnings Scheduled For October 24, 2014
Oct 24 / Benzinga
3 Stocks Reiterated As A Buy: BMY, BIDU, BIIB
Oct 28 / TheStreet.com
Stocks: 4 things to know before the open
Oct 24 / CNNMoney.com
Bristol-Myers Squibb Company (BMY): New Analyst Report from Zacks Equity Research - Z...
Oct 27 / Zacks.com
Must Watch Stocks for Today
Oct 24 / Benzinga
Company News for October 27, 2014 - Corporate Summary
Oct 27 / Zacks.com
Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog
Oct 22 / Zacks.com
#PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations
Oct 27 / Benzinga
Is It Time to Buy Eli Lilly & Co.'s Stock?
Oct 21 / MotleyFool.com
How Gilead Sciences Inc. Isn't Gouging Hepatitis C Patients, in 1 Simple Infographic
Oct 26 / MotleyFool.com
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Oct 20 / MotleyFool.com
Profit From the Longer Life Spans, Part 1
Oct 25 / TheStreet.com
This Drug Could Outsell Medical Marijuana
Oct 19 / MotleyFool.com
Bristol Myers Squibb (BMY) Earnings Report: Q3 2014 Conference Call Transcript
Oct 24 / TheStreet.com
Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog
Oct 17 / Zacks.com
Bristol-Myers Beats on Q3 Earnings, Maintains Guidance - Analyst Blog
Oct 24 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.